Sameer A. Alvi

Sameer A. Alvi

Auto-generated profile, based on publicly available information

Sameer A. Alvi

Department of Otolaryngology – Head & Neck Surgery, University of Iowa Hospitals and Clinics, Iowa City, IA, USA

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
30 November 2017 in Cancer Research
Verified
Journal Article
Closed access
PDF file
JNJacob New
Jacob New
LALevi Arnold
Levi Arnold
MAMegha Ananth
Megha Ananth
SASameer Alvi
Sameer Alvi
MTMackenzie Thornton
Mackenzie Thornton
STSufi Mary Thomas
Sufi Mary Thomas
Despite therapeutic advancements, there has been little change in the survival of patients with head and neck squamous cell carcinoma (HNSCC). Recent results suggest that cancer-associated fibroblasts (CAF) drive progression of this disease. Here, we report that autophagy is upregulated in HNSCC-associated CAFs, where it is responsible for key pathogenic contributions in this disease. Autophagy is fundamentally involved in cell degradation, but there is emerging evidence that suggests it is also important for cellular secretion. Thus, we hypothesized that autophagy-dependent secretion of tumor-promoting factors by HNSCC-associated CAFs may explain their role in malignant development. In support of this hypothesis, we observed a reduction in CAF-facilitated HNSCC progression after blocking CAF autophagy. Studies of cell growth media conditioned after autophagy blockade revealed levels of secreted IL6, IL8, and other cytokines were modulated by autophagy. Notably, when HNSCC cells were cocultured with normal fibroblasts, they upregulated autophagy through IL6, IL8, and basic fibroblast growth factor. In a mouse xenograft model of HNSCC, pharmacologic inhibition of Vps34, a key mediator of autophagy, enhanced the antitumor efficacy of cisplatin. Our results establish an oncogenic function for secretory autophagy in HNSCC stromal cells that promotes malignant progression. Cancer Res; 77(23); 6679–91. ©2017 AACR.

8 March 2017 in The Laryngoscope
Verified
Journal Article
Closed access
PDF file
NCNaweed Chowdhury
Naweed Chowdhury
SASameer Alvi
Sameer Alvi
KKKyle Kimura
Kyle Kimura
OTOssama Tawfik
Ossama Tawfik
PMPradip Manna
Pradip Manna
LHLarry Hoover
Larry Hoover

1 June 2017 in International Journal of Pediatric Otorhinolaryngology
Verified
Journal Article
Closed access
SASameer Alvi
Sameer Alvi
OKOmar Karadaghy
Omar Karadaghy
MMMichelle Manalang
Michelle Manalang
RWRobert Weatherly
Robert Weatherly

29 October 2018 in Annals of Otology, Rhinology & Laryngology
Verified
Journal Article
Closed access
AMAdam McCann
Adam McCann
SASameer A. Alvi
Sameer A. Alvi
JNJessica Newman
Jessica Newman
KKKiran Kakarala
Kiran Kakarala
HSHinrich Staecker
Hinrich Staecker
JVJennifer A. Villwock
Jennifer A. Villwock
Cervicofacial actinomycosis is an uncommon indolent infection caused by Actinomyces spp that typically affects individuals with innate or adaptive immunodeficiencies. Soft tissues of the face and neck are most commonly involved. Actinomyces osteomyelitis is uncommon; involvement of the skull base and temporal bone is exceedingly rare. The authors present a unique case of refractory cervicofacial actinomycosis with development of skull base and temporal bone osteomyelitis in an otherwise healthy individual. Case report with literature review. A 69-year-old man presented with a soft tissue infection, culture positive for Actinomyces, over the right maxilla. Previous unsuccessful treatment included local debridement and 6 weeks of intravenous ceftriaxone. He was subsequently treated with conservative debridement and a prolonged course of intravenous followed by oral antibiotic. However, he eventually required multiple procedures, including maxillectomy, pterygopalatine fossa debridement, and a radical mastoidectomy to clear his disease. Postoperatively he was gradually transitioned off intravenous antibiotics. Cervicofacial actinomycosis involves soft tissue surrounding the facial skeleton and oral cavity and is typically associated with a history of mucosal trauma, surgery, or immunodeficiency. The patient was appropriately treated but experienced disease progression and escalation of therapy. Although actinomycosis is typically not an aggressive bacterial infection, this case illustrates the need for prompt recognition of persistent disease and earlier surgical intervention in cases of recalcitrant cervicofacial actinomycosis. Chronic actinomycosis has the potential for significant morbidity.

5 November 2023 in Annals of Otology, Rhinology & Laryngology
Verified
Journal Article
Closed access
AMAbigail E. Moore
Abigail E. Moore
SASameer A. Alvi
Sameer A. Alvi
OTOsama Tarabichi
Osama Tarabichi
VZVivian L. Zhu
Vivian L. Zhu
MBMarisa R. Buchakjian
Marisa R. Buchakjian
Objective: The overall 5-year survival for oral squamous cell carcinoma (OSCC) has not changed in the last 20 years despite advances in treatment. Lymphovascular invasion (LVI) has been shown to be a negative prognostic factor in other cancers, however its role in the prognosis of OSCC remains unclear. This study aims to determine if LVI is a predictor of cervical lymph node metastasis and/or recurrence in OSCC. Methods: We conducted a retrospective cohort review of patients from our institutional cancer registry who were treated for OSCC between 2004 and 2018. Patient demographics, surgical pathology results, and clinical outcome data were collected. A multivariable logistic regression analysis was performed to determine if LVI was an independent predictor of cervical lymph node metastasis and/or recurrence. Results: 442 patients were included, 32.8% were female and median age at time of diagnosis was 61.2 years. LVI was present in 32.8% of patients. When controlled for age, sex, t-classification, perineural invasion, depth of invasion (DOI), and margin status, LVI was a significant predictor of the presence of cervical node metastasis (OR: 3.42, CI: 2.17-5.39, P < .001). There was no significant association found between LVI and local recurrence (OR: 1.03, CI: 0.57-1.84, P = .92), regional recurrence (OR: 1.10, CI: 0.57-2.11, P = .78), or distant recurrence (OR: 1.59, CI: 0.87-2.94, P = .13). Conclusion: The results of this study suggest that LVI is a significant predictor of the presence of cervical lymph node metastasis at presentation independent of other known prognostic factors. LVI, however, was not found to be a significant independent predictor of locoregional or distant recurrence. Level of Evidence: Level III

21 June 2018 in Annals of Otology, Rhinology & Laryngology
Verified
Journal Article
Closed access
PJPaul D. Judge
Paul D. Judge
SASameer A. Alvi
Sameer A. Alvi
KTKareem O. Tawfik
Kareem O. Tawfik
Objectives: To ascertain motivations and priorities for neurotology fellowship applicants and program directors during the match process. Methods: Anonymous online survey distributed to 20 fellowship program directors and 40 current and incoming neurotology fellows. A 5-point Likert scale was used to assess the priorities of fellowship applicants and program directors in the match process. Results: Twenty-four of 40 (60%) current or incoming fellows and 14 of 20 (65%) program directors responded to the survey. Fellows rated surgical exposure and volume as their highest priorities. In addition to neurotology case load, fellows highly valued exposure to otologic surgery. Salary, call, and work/life balance were among the lowest rated factors among fellows. Program directors attached the highest priority to the applicant interview performance, followed by strength of letters of recommendation and quality of prior research. Ethnicity, sex, and likelihood of an applicant ranking a program highly were the lowest rated factors among program directors. Conclusion: Among neurotology fellows, operative case load and breadth of surgical exposure are highly valued components of accredited fellowship training. Among neurotology fellowship program directors, candidates’ performance during the fellowship interview appears to be highly valued, more so than the strength of applicants’ letters of recommendation or prior research credentials.